Stroke is one of the leading causes of neurological disability worldwide. It occurs when blood flow to a part of the brain is suddenly interrupted or reduced, depriving that area of oxygen and nutrients. This can be due to a blockage in a cerebral blood vessel (ischemic stroke) or a rupture or bleeding in a blood vessel in the brain (hemorrhagic stroke).
When this happens, brain nerve cells begin to deteriorate or die within minutes to hours. This can lead to weakness or paralysis on one side of the body, confusion or loss of speech, vision problems, difficulty swallowing, and mood and memory disturbances. Traditional post-stroke treatments, such as clot-dissolving drugs when appropriate, managing risk factors (like high blood pressure), and neurological rehabilitation (physical, occupational, and speech therapy), are cornerstones of stroke treatment protocols. However, they cannot fully replace lost nerve cells. Although prompt intervention and rehabilitation can improve outcomes, some patients may experience long-term neurological impairment. This has led to increased interest in stem cells within stroke neurorehabilitation research, as they offer a new avenue for repairing damaged nerve tissue and stimulating functional recovery.
How might stem cells help treat stroke?
When combined with stroke neurorehabilitation programs, stem cells work through several mechanisms, including:
1-Releasing growth factors that help protect remaining nerve cells.
2-Reducing inflammation in the brain after the injury.
3-Stimulating the formation of new blood vessels in the affected area.
4-Supporting communication between nerve cells and improving neurological recovery.
5-Contributing, in some research models, to the formation of cells with new neurological characteristics.
How might stem cells help treat stroke?
When combined with stroke neurorehabilitation programs, stem cells work through several mechanisms, including:
1-Releasing growth factors that help protect remaining nerve cells.
2-Reducing inflammation in the brain after the injury.
3-Stimulating the formation of new blood vessels in the affected area.
4-Supporting communication between nerve cells and improving neurological recovery.
5-Contributing, in some research models, to the formation of cells with new neurological characteristics.
These effects may translate into gradual improvements in movement, speech, or cognitive functions for some patients, but the response varies significantly from case to case. Recent research suggests that stem cell therapy after stroke may be promising, particularly in improving certain neurological functions and reducing motor deficits in some patients. Research also indicates that some stem cells do not need to fully differentiate into fully formed neurons to be beneficial; the therapeutic effect may come from the chemical messengers released by these stem cells, such as growth factors and immune-regulating cytokines.
These effects may translate into gradual improvements in movement, speech, or cognitive functions for some patients, but the response varies significantly from case to case. Recent research suggests that stem cell therapy after stroke may be promising, particularly in improving certain neurological functions and reducing motor deficits in some patients. Research also indicates that some stem cells do not need to fully differentiate into fully formed neurons to be beneficial; the therapeutic effect may come from the chemical messengers released by these stem cells, such as growth factors and immune-regulating cytokines.
Who might be a suitable candidate for stem cell therapy?
Stem cell therapy may be considered in some cases of persistent neurological deficits following a stroke, especially when the goal is to support rehabilitation and improve residual function. However, patient evaluation remains crucial, as some cases may not be suitable due to the severity of the injury, the presence of co-existing conditions, or overall instability. Researchers are also studying the impact of treatment timing, the type of cells used, and the method of administration to achieve the best possible outcomes. However, larger studies are still needed to confirm long-term efficacy and identify the groups that would benefit most.
At the I.D. Stem Cells and Genome Institute, we keep abreast of the latest scientific developments in the field of stem cell and gene therapy and regenerative medicine. If you are interested in learning more about the potential benefits of these treatments and the latest research findings, please feel free to contact us.
Who might be a suitable candidate for stem cell therapy?
Stem cell therapy may be considered in some cases of persistent neurological deficits following a stroke, especially when the goal is to support rehabilitation and improve residual function. However, patient evaluation remains crucial, as some cases may not be suitable due to the severity of the injury, the presence of co-existing conditions, or overall instability. Researchers are also studying the impact of treatment timing, the type of cells used, and the method of administration to achieve the best possible outcomes. However, larger studies are still needed to confirm long-term efficacy and identify the groups that would benefit most.
At the I.D. Stem Cells and Genome Institute, we keep abreast of the latest scientific developments in the field of stem cell and gene therapy and regenerative medicine. If you are interested in learning more about the potential benefits of these treatments and the latest research findings, please feel free to contact us.
